Artimplant AB Product Pipeline Analysis

Publication Date	August 2008
Publisher	Global Markets Direct
Product Type	Report
Pages	38
ISBN Number	not applicable
Product Code	GMD04667

Price

£490.00
approximately: $749 | €546

PDF

Order above formats by FAX

Summary

This report is an insightful source for data, analysis and strategic insights into a Artimplant AB's pipeline and investigational products. The report also provides details on clinical trials covering trial phase, description, investigator information, primary and secondary end-points and trial results for products in development.

Scope

Details of development stage by sector and equipment type.
Pipeline products grouped by therapy area, development stage and trial phase.
Detailed information on clinical trials covering trial phase, description, investigator .nformation, primary and secondary end-points and trial results.
Trial updates, trial start and end dates, patient numbers and the trials primary outcome measures, secondary outcome measures.
Product updates covering estimated approval dates and estimated launch dates.
Descriptions of novel technologies relating to pipeline products of the company.
Patents and patent applications covered for the product.
News updates on key events relating to the product and its development.

Reasons to buy

A single source to fulfill competitor information relating to products in development.
Identify pipeline products that are potential competitor to your product lines.

Understand a company's strategic position by accessing detailed independent intelligence on its product pipeline.

Access clinical trial information to map trial results and plan targeted marketing activities.
Take corrective measures on your own development programs and R&D initiatives based on regulatory events of competitor product pipelines.
Identification of potential investment opportunities.
Build up knowledge base for potential distribution and marketing partners.
Helps avoid patent infringement.
Timelines from concept to market lets you keep track of market potential build for a new product.

Assess a company's future growth by determining its pipeline depth, for probable acquisition opportunities.

Content

1 List of Tables
- 1.2 List of Figures
2 Company Snapshot
- 2.1 Key Information
- 2.2 Company Overview
- 2.3 Financial Performance
- 2.4 Industry Outlook Orthopedic Devices
3 Business Description
- 3.1 Business Overview
- 3.2 Major Products and Services
  - 3.2.1 Overview
4 History
5 Competitors
6 Key Employees
7 Key Employee Biographies
8 Company Statement
9 Locations And Subsidiaries
- 9.1 Head Office
- 9.2 Other Locations & Subsidiaries
10 Recent Developments
- 10.1 Financial Announcements
  - 10.1.1 Aug 07, 2008: Artimplant Declares 1H 2008 Results
  - 10.1.2 May 06, 2008: Artimplant Reports Q1 2008 Results
  - 10.1.3 Feb 22, 2008: Artimplant Declares Q4 2007 Results
  - 10.1.4 Nov 09, 2007: Artimplant Declares Q3 2007 Results
  - 10.1.5 Aug 08, 2007: Artimplant Declares H1 2007 Results
  - 10.1.6 May 03, 2007: Artimplant Declares Q1 2007 Results
- 10.2 Corporate Communications
  - 10.2.1 May 07, 2008: Artimplant Announce Board Changes
  - 10.2.2 Mar 11, 2008: Artimplant Announces Board Changes
- 10.3 Product News
  - 10.3.1 Jan 30, 2007: First Case Studies On Artelon Foot Applications Presented
  - 10.3.2 Jul 14, 2006: Artimplant Receives CE Mark For Three New Artelon Spacers
  - 10.3.3 Mar 27, 2006: Wrist Device For Osteoarthritis Receives CE Mark
  - 10.3.4 Jul 05, 2005: Artimplant Boosts Its Commercial Base Through CE-Mark For Two New Products Within Odontology And Craniomaxillofacial Surgery
- 10.4 Product Approvals
  - 10.4.1 Jul 14, 2006: Artimplant Receives CE Mark For Three New Artelon Spacers
  - 10.4.2 Mar 27, 2006: Wrist Device For Osteoarthritis Receives CE Mark
  - 10.4.3 Jul 05, 2005: Artimplant Boosts Its Commercial Base Through CE-Mark For Two New Products Within Odontology And Craniomaxillofacial Surgery
- 10.5 Clinical Trials
  - 10.5.1 Jan 30, 2007: First Case Studies On Artelon Foot Applications Presented
11 Artimplant AB Pipeline Products
- 11.1 Artimplant AB Product Pipeline Analysis
  - 11.1.1 Artimplant AB Pipeline Products By Equipment Type
  - 11.1.2 Artimplant AB Pipeline Products By Development Stage
  - 11.1.3 Artimplant AB Pipeline Products By Therapy Area
  - 11.1.4 Artimplant AB Pipeline Products By Clinical Trials
  - 11.1.5 Artimplant AB Pipeline Products By News Summary
- 11.2 Artelon Dru Spacer
  - 11.2.1 Product Description
  - 11.2.2 Product Status
  - 11.2.3 Clinical Trials
  - 11.2.4 Product Milestone
- 11.3 Artelon MTP Spacer
  - 11.3.1 Product Description
  - 11.3.2 Product Status
  - 11.3.3 Clinical Trials
  - 11.3.4 Product Milestone
  - 11.3.5 Product Patent Details
- 11.4 Artelon Bone Scaffold
  - 11.4.1 Product Description
  - 11.4.2 Product Status
  - 11.4.3 Product Milestone
- 11.5 Spacer for hand and wrist joints
  - 11.5.1 Product Description
  - 11.5.2 Product Status
- 11.6 Artelon for CMF
  - 11.6.1 Product Description
  - 11.6.2 Product Status
12 Appendix
- 12.1 Methodology
  - 12.1.1 Coverage
  - 12.1.2 Secondary Research
  - 12.1.3 Primary Research
  - 12.1.4 Expert Panel Validation
- 12.2 Contact Us
- 12.3 About Global Markets Direct
- 12.4 Disclaimer
1 List of Tables
- Table 1: Artimplant AB,Key Facts
- Table 2: Artimplant AB, Key Employees,
- Table 3: Artimplant AB, Subsidiaries
- Table 4: Artimplant AB Pipeline Products by Equipment Type
- Table 5: Artimplant AB Pipeline Products By Development Stage
- Table 6: Artimplant AB Pipeline Products By Therapy Area
- Table 7: Artimplant AB Pipeline Products By Clinical Trials
- Table 8: Artimplant AB Pipeline Products By News Summaries
- 1.2 List of Figures
- Figure 1: Artimplant AB Pipeline Products By Equipment Type
- Figure 2: Artimplant AB Pipeline Products By Equipment Type
- Figure 3: Artimplant AB Pipeline Products By Development Stage
- Figure 4: Global Markets Direct Methodology